Brainsway Ltd. - Understand $bway stock

$BWAY Market Cap: $463.7 Million

Research Board Inbox Deep Research Not Interested Shortlisted

Financial Snapshot

Revenue

$31.79M

TTM

Gross Margin

73.79%

TTM

Net Earnings

-$4.197M

TTM

Current Assets

$55.47M

Q4 2023

Current Liabilities

$9.761M

Q4 2023

Current Ratio

568.23%

Q4 2023

Total Assets

$62.97M

Q4 2023

Total Liabilities

$21.39M

Q4 2023

Book Value

$41.58M

Q4 2023

Cash

$45.99M

Q4 2023

P/E

-110.5

Nov 29, 2024 EST

Free Cash Flow

$2.441M

TTM

Revenues

Revenue YoY Change

Revenues

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006
Revenue	$31.79M	$27.18M	$29.66M	$22.06M	$23.10M	$16.40M	$11.15M	$11.52M	$6.800M	$3.380M	$1.190M	$350.0K	$270.0K	$90.00K	$0.00	$0.00	$0.00	$0.00
YoY Change	16.96%	-8.36%	34.46%	-4.52%	40.89%	47.12%	-3.29%	69.47%	101.18%	184.03%	240.0%	29.63%	200.0%

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006
Revenue	$31.79M	$27.18M	$29.66M	$22.06M	$23.10M	$16.40M	$11.15M	$11.52M	$6.800M	$3.380M	$1.190M	$350.0K	$270.0K	$90.00K	$0.00	$0.00	$0.00	$0.00
Cost Of Revenue	$8.308M	$7.129M	$6.599M	$5.058M	$5.129M	$3.589M	$2.595M	$2.427M	$1.466M	$656.0K	$200.0K	$40.00K	$30.00K	$10.00K	$0.00
Gross Profit	$23.48M	$20.05M	$23.06M	$17.00M	$17.97M	$12.81M	$8.550M	$9.097M	$5.334M	$2.724M	$990.0K	$310.0K	$240.0K	$80.00K	$0.00
Gross Profit Margin	73.86%	73.77%	77.75%	77.07%	77.8%	78.11%	76.72%	78.94%	78.44%	80.59%	83.19%	88.57%	88.89%	88.89%

Selling, General & Admin Expense

Research & Development

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006
Selling, General & Admin	$21.77M	$24.74M	$21.26M	$15.65M	$18.49M	$11.74M	$9.798M	$7.325M	$5.706M	$3.552M	$2.060M	$1.340M	$2.100M	$1.070M	$760.0K	$600.0K	$290.0K	$80.00K
YoY Change	-12.0%	16.39%	35.79%	-15.34%	57.56%	19.78%	33.76%	28.37%	60.64%	72.43%	53.73%	-36.19%	96.26%	40.79%	26.67%	106.9%	262.5%
% of Gross Profit	92.73%	123.41%	92.19%	92.09%	102.89%	91.63%	114.6%	80.52%	106.97%	130.4%	208.08%	432.26%	875.0%	1337.5%
Research & Development	$6.665M	$7.678M	$6.286M	$5.736M	$7.837M	$6.125M	$5.308M	$3.757M	$4.071M	$6.407M	$3.670M	$4.420M	$5.080M	$4.270M	$1.930M	$930.0K	$930.0K	$220.0K
YoY Change	-13.19%	22.14%	9.59%	-26.81%	27.95%	15.39%	41.28%	-7.71%	-36.46%	74.58%	-16.97%	-12.99%	18.97%	121.24%	107.53%	0.0%	322.73%
% of Gross Profit	28.39%	38.3%	27.26%	33.74%	43.61%	47.82%	62.08%	41.3%	76.32%	235.21%	370.71%	1425.81%	2116.67%	5337.5%
Depreciation & Amortization	$1.337M	$411.0K	$1.686M	$2.679M	$2.795M	$1.228M	$1.072M	$649.0K	$611.0K	$336.0K	$210.0K	$110.0K	$90.00K	$50.00K	$30.00K	$20.00K	$10.00K	$0.00
YoY Change	225.3%	-75.62%	-37.07%	-4.15%	127.61%	14.55%	65.18%	6.22%	81.85%	60.0%	90.91%	22.22%	80.0%	66.67%	50.0%	100.0%
% of Gross Profit	5.69%	2.05%	7.31%	15.76%	15.55%	9.59%	12.54%	7.13%	11.45%	12.33%	21.21%	35.48%	37.5%	62.5%
Operating Expenses	$28.44M	$7.678M	$28.06M	$21.83M	$26.45M	$17.92M	$15.16M	$11.17M	$9.839M	$10.00M	$5.270M	$5.830M	$7.230M	$5.380M	$2.730M	$1.560M	$1.230M	$300.0K
YoY Change	270.36%	-72.63%	28.54%	-17.47%	47.57%	18.21%	35.78%	13.49%	-1.62%	89.77%	-9.61%	-19.36%	34.39%	97.07%	75.0%	26.83%	310.0%
Operating Profit	-$4.959M	$12.37M	-$4.999M	-$4.829M	-$8.476M	-$5.114M	-$6.611M	-$2.069M	-$4.505M	-$7.277M	-$4.280M	-$5.520M	-$6.990M	-$5.300M	-$2.730M
YoY Change	-140.09%	-347.45%	3.52%	-43.03%	65.74%	-22.64%	219.53%	-54.07%	-38.09%	70.02%	-22.46%	-21.03%	31.89%	94.14%

Interest Expenses

Interest Expenses To Operating Income %

Other Expense/Income

Interest & Other Expense/Income

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006
Interest Expense	$1.013M	-$298.0K	$303.0K	-$66.00K	-$590.0K	-$568.0K	$99.00K	-$328.0K	-$65.00K	$433.0K	-$2.810M	-$430.0K	-$610.0K	-$6.850M	-$5.510M	-$1.200M	-$1.270M
YoY Change	-439.93%	-198.35%	-559.09%	-88.81%	3.87%	-673.74%	-130.18%	404.62%	-115.01%	-115.41%	553.49%	-29.51%	-91.09%	24.32%	359.17%	-5.51%
% of Operating Profit		-2.41%
Other Income/Expense, Net	-$1.049M	-$53.00K	-$1.723M	-$253.0K	-$840.0K	-$588.0K	-$373.0K		$483.0K	-$21.08K	-$20.00K	$210.0K	$780.0K	$11.02M	$270.0K	$510.0K	$110.0K	-$10.00K
YoY Change	1879.25%	-96.92%	581.03%	-69.88%	42.86%	57.64%			-2391.16%	5.41%	-109.52%	-73.08%	-92.92%	3981.48%	-47.06%	363.64%	-1200.0%

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

Net Profits/Loss YoY Change

Basic EPS

Net Income To Revenue Ratio

Pretax & Net Income

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006
Pretax Income	-$3.946M	-$13.03M	-$6.419M	-$5.148M	-$9.906M	-$6.270M	-$6.885M	-$2.397M	-$4.087M	-$6.545M	-$7.110M	-$5.740M	-$6.820M	-$1.140M	-$7.980M	-$2.260M	-$2.390M	-$300.0K
YoY Change	-69.73%	103.05%	24.69%	-48.03%	57.99%	-8.93%	187.23%	-41.35%	-37.56%	-7.95%	23.87%	-15.84%	498.25%	-85.71%	253.1%	-5.44%	696.67%
Income Tax	$251.0K	$315.0K	$43.00K	$237.0K	$422.0K	$209.0K	$169.0K		$0.00	$27.74K	$30.00K	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$4.197M	-$13.35M	-$6.462M	-$5.385M	-$10.33M	-$6.479M	-$7.054M	-$2.397M	-$4.087M	-$6.545M	-$7.130M	-$5.740M	-$6.820M	-$1.140M	-$7.980M	-$2.260M	-$2.390M	-$300.0K
YoY Change	-68.56%	106.58%	20.0%	-47.86%	59.41%	-8.15%	194.28%	-41.35%	-37.56%	-8.2%	24.22%	-15.84%	498.25%	-85.71%	253.1%	-5.44%	696.67%
Net Earnings / Revenue	-13.2%	-49.12%	-21.79%	-24.41%	-44.71%	-39.51%	-63.29%	-20.8%	-60.1%	-193.64%	-599.16%	-1640.0%	-2525.93%	-1266.67%
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.13	-$0.40	-$207.4K	-$239.8K	-$503.7K	-$389.4K	-$477.6K	-$165.2K	-$282.6K	-$462.2K	-$554.0K	-$471.7K	-$576.5K	-$26.77K	-$207.6K	-$63.45K	-$68.32K	-$11.40K

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006
Cash & Short-Term Investments	$45.99M	$47.85M	$57.35M	$17.18M	$21.90M	$9.069M	$14.56M	$9.759M	$11.94M	$18.34M	$11.94M	$9.290M	$9.660M	$10.25M	$6.060M	$7.210M	$6.170M
YoY Change	-3.9%	-16.56%	233.77%	-21.53%	141.43%	-37.71%	49.19%	-18.27%	-34.9%	53.6%	28.53%	-3.83%	-5.76%	69.14%	-15.95%	16.86%
Cash & Equivalents	$0.00	$40.27M	$1.450M	$1.500M	$10.03M	$3.000M	$14.51M	$9.174M	$4.810M	$12.16M	$0.00	$1.060M	$6.920M	$10.25M	$2.860M	$3.660M	$650.0K
Short-Term Investments	$35.47M	$40.55M	$41.88M	$1.725M	$10.26M	$3.104M	$50.00K	$585.0K	$590.0K	$1.080M	$5.399M	$5.960M	$2.750M	$0.00	$3.200M	$3.560M	$5.520M
Other Short-Term Assets	$1.563M	$950.0K	$1.178M	$672.0K	$672.0K	$322.0K			$125.0K	$58.00K	$15.53K	$60.00K		$0.00	$0.00
YoY Change	64.53%	-19.35%	75.3%	0.0%	108.7%				115.52%	273.37%	-74.11%
Inventory	$3.717M	$3.837M
Prepaid Expenses
Receivables	$3.780M	$4.844M	$6.332M	$5.790M	$5.578M	$3.236M	$2.419M	$2.492M	$2.570M	$1.200M	$2.568M	$420.0K	$0.00	$10.00K	$0.00
Other Receivables	$420.0K	$606.0K	$588.0K	$654.0K	$684.0K	$851.0K	$909.0K	$859.0K	$230.0K	$230.0K	$231.0K	$190.0K	$200.0K	$1.630M	$310.0K
Total Short-Term Assets	$55.47M	$58.09M	$65.45M	$24.30M	$28.83M	$13.48M	$17.89M	$13.11M	$125.0K	$58.00K	$14.86M	$9.950M	$9.860M	$11.89M	$6.370M	$7.590M	$6.530M	$100.0K
YoY Change	-4.52%	-11.24%	169.35%	-15.72%	113.9%	-24.65%	36.44%	10388.0%	115.52%	-99.61%	49.39%	0.91%	-17.07%	86.66%	-16.07%	16.23%	6430.0%
Property, Plant & Equipment	$5.790M	$5.346M	$9.331M	$9.550M	$9.739M	$7.626M	$7.091M	$6.821M	$7.330M	$5.890M	$7.329M	$700.0K	$470.0K	$400.0K	$120.0K	$80.00K	$80.00K	$20.00K
YoY Change	8.31%	-42.71%	-2.29%	-1.94%	27.71%	7.54%	3.96%	-6.94%	24.45%	-19.63%	947.0%	48.94%	17.5%	233.33%	50.0%	0.0%	300.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$1.717M	$1.042M	$954.0K	$163.0K	$168.0K	$146.0K	$25.00K	$24.00K	$30.00K	$30.00K	$34.00K	$20.00K	$20.00K	$20.00K	$350.0K	$0.00	$0.00
YoY Change	64.78%	9.22%	485.28%	-2.98%	15.07%	484.0%	4.17%	-20.0%	0.0%	-11.76%	70.0%	0.0%	0.0%	-94.29%
Other Assets					$0.00	$2.352M	$2.009M				$0.00
YoY Change					-100.0%	17.07%
Total Long-Term Assets	$7.507M	$6.388M	$10.29M	$9.713M	$9.907M	$10.12M	$9.143M	$6.854M	$22.12M	$25.71M	$7.379M	$760.0K	$530.0K	$460.0K	$510.0K	$110.0K	$120.0K	$20.00K
YoY Change	17.52%	-37.89%	5.89%	-1.96%	-2.14%	10.73%	33.4%	-69.01%	-13.99%	248.45%	870.92%	43.4%	15.22%	-9.8%	363.64%	-8.33%	500.0%
Total Assets	$62.97M	$64.48M	$75.73M	$34.01M	$38.74M	$23.60M	$27.03M	$19.96M	$22.24M	$25.77M	$22.24M	$10.71M	$10.39M	$12.35M	$6.880M	$7.700M	$6.650M	$120.0K
YoY Change
Accounts Payable	$1.415M	$1.116M	$1.102M	$781.0K	$1.320M	$2.243M	$1.631M	$810.0K	$940.0K	$1.530M	$944.0K	$800.0K	$670.0K	$440.0K	$450.0K	$300.0K	$260.0K	$90.00K
YoY Change	26.79%	1.27%	41.1%	-40.83%	-41.15%	37.52%	101.36%	-13.83%	-38.56%	62.08%	18.0%	19.4%	52.27%	-2.22%	50.0%	15.38%	188.89%
Accrued Expenses	$4.545M	$4.177M	$4.038M	$3.238M	$2.836M	$3.228M			$1.101M	$1.119M	$724.0K	$380.0K
YoY Change	8.81%	3.44%	24.71%	14.17%	-12.14%				-1.61%	54.56%	90.52%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00	$0.00	$0.00	$750.0K	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
YoY Change					-100.0%
Long-Term Debt Due	$232.0K	$234.0K	$500.0K	$429.0K	$414.0K
YoY Change	-0.85%	-53.2%	16.55%	3.62%
Total Short-Term Liabilities	$9.761M	$8.141M	$9.067M	$6.800M	$6.718M	$8.339M	$6.133M	$4.395M	$1.101M	$1.119M	$4.896M	$1.680M	$1.410M	$2.230M	$9.740M	$560.0K	$410.0K	$510.0K
YoY Change	19.9%	-10.21%	33.34%	1.22%	-19.44%	35.97%	39.54%	299.18%	-1.61%	-77.14%	191.43%	19.15%	-36.77%	-77.1%	1639.29%	36.59%	-19.61%
Long-Term Debt	$239.0K	$254.0K	$254.0K	$243.0K	$663.0K	$2.083M	$2.727M	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$980.0K
YoY Change	-5.91%	0.0%	4.53%	-63.35%	-68.17%	-23.62%											-100.0%
Other Long-Term Liabilities	$11.39M	$10.69M	$9.086M	$7.334M	$7.135M	$6.228M	$5.449M	$5.282M	$4.450M	$4.720M	$4.452M	$4.120M	$2.410M	$2.140M	$460.0K	$4.240M	$4.130M
YoY Change	6.61%	17.6%	23.89%	2.79%	14.56%	14.3%	3.16%	18.7%	-5.72%	6.02%	8.06%	70.95%	12.62%	365.22%	-89.15%	2.66%
Total Long-Term Liabilities	$11.63M	$10.94M	$9.340M	$7.577M	$7.798M	$8.311M	$8.176M	$5.282M	$4.450M	$4.720M	$4.452M	$4.120M	$2.410M	$2.140M	$460.0K	$4.240M	$4.130M	$980.0K
YoY Change	6.32%	17.12%	23.27%	-2.83%	-6.17%	1.65%	54.79%	18.7%	-5.72%	6.02%	8.06%	70.95%	12.62%	365.22%	-89.15%	2.66%	321.43%
Total Liabilities	$21.39M	$19.08M	$18.41M	$14.38M	$14.52M	$16.65M	$14.31M	$9.677M	$9.350M	$10.19M	$9.348M	$5.800M	$3.820M	$4.370M	$10.20M	$4.800M	$4.540M	$1.480M
YoY Change	12.11%	3.66%	28.03%	-0.96%	-12.82%	16.36%	47.87%	3.5%	-8.24%	9.01%	61.17%	51.83%	-12.59%	-57.16%	112.5%	5.73%	206.76%

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

Preferred Stock

Treasury Stock Shares

Stock Issuance & Repurchase

Ownership Data

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006
Basic Shares Outstanding
Diluted Shares Outstanding
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Free Cash Flow Margin

Dividends

Stock Price

Market Cap: $463.65 Million

About Brainsway Ltd.

Brainsway Ltd. engages in the development and sale of non-invasive neurostimulation treatments using the proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder (MDD) and obsessive-compulsive disorder (OCD). The firm primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.

Industry: Surgical & Medical Instruments & Apparatus Peers: Alpha Tau Medical Ltd. Nano-X Imaging Ltd.